Radiesse nodules — dispersion, not reversal
You will have heard that hyaluronic acid filler can be dissolved if something goes wrong. For Radiesse there is no such agent. It is a calcium compound, and the hyaluronic acid enzyme does nothing to it. Nodules are uncommon — but the fact that they cannot be reversed is what makes the whole treatment design more conservative. There are no prices in this article.
The short answer
Radiesse is calcium hydroxylapatite (CaHA) microspheres suspended in a gel carrier. It is not a hyaluronic acid, so hyaluronidase does not break it down. “If it goes wrong we can just dissolve it” does not apply here. The methods used when a nodule forms do not dissolve anything; they dilute the deposit in place with sterile water or saline, break it up mechanically, and leave the body to resorb it. Nodules themselves are uncommon — one in 117 patients (0.9%) in the manufacturer’s nasolabial fold trial. But because it cannot be reversed, the prevention side of the standard matters more. Dilution and plane are covered in Radiesse in Daegu: dilution ratio and injection plane. Miso Clinic is at 4F Bombom Building, 125 Dongdeok-ro, Jung-gu, Daegu, South Korea, by Exit 1 of Kyungpook National University Hospital Station. +82-53-428-2700. Weekdays 11:00–19:00, Saturday 10:00–16:00 (no lunch break); closed Sundays and public holidays.
Why it does not dissolve
Hyaluronidase is, as the name says, the enzyme that breaks down hyaluronic acid. Like a key to a lock, it has one target. The substance in Radiesse is not hyaluronic acid but a calcium compound close to the mineral of bone and teeth, so there is nothing for the enzyme to bind.
| Product | Main substance | Dissolving enzyme |
|---|---|---|
| HA fillers · BYRYZN | Hyaluronic acid | Yes — hyaluronidase |
| Radiesse | Calcium hydroxylapatite | None |
| Juvelook · Sculptra | PDLLA · PLLA | None |
One point is easy to misread. There are accounts of hyaluronidase being used when managing a Radiesse nodule. That is not dissolving the Radiesse: it is an adjunct, dissolving the surrounding native hyaluronic acid so the deposit can be dispersed more easily, and the evidence for it is reported as anecdotal. That is a different claim from “it can be dissolved.”
How often do they happen?
The manufacturer’s regulatory submission contains figures. They are uncommon.
| Study | Patients | Nodules |
|---|---|---|
| Nasolabial folds | 117 | 1 (0.9%) |
| HIV-associated facial lipoatrophy | 100 | 0 |
Read the numbers carefully, though. Those studies examined deep, volumising use — nasolabial folds and lipoatrophy. The hyperdiluted, superficially spread skin-booster use that is common today is not the use those trials examined, so 0.9% cannot simply be carried across to every Radiesse treatment.
And the site changes everything. The instructions for use carry an explicit warning that safety and effectiveness in the lips have not been established, and that nodules associated with Radiesse injected into the lips have been published. We do not use Radiesse in the lips.
What is done if a nodule forms
A stepwise approach to CaHA focal accumulations was published in a peer-reviewed journal in 2024. Below is that framework put into plain terms; which step applies is decided by the treating physician, looking at the site and the finding.
| Level | What is done |
|---|---|
| Level 0 · observation | Nothing is done; the body resorbs it. Reported to resolve in most cases, but this can take upwards of two years |
| Level 1 · first line | Hyperdilution in situ with sterile water or saline, then firm compression and massage, vibration or microneedling to break it up. Repeated as needed |
| Level 2 · second line | Intralesional injection (corticosteroids, 5-fluorouracil) or fractional laser have been reported |
| Level 3 · last resort | Physical extraction with needle or small incision, or surgical removal |
Level 1 is the heart of it, and what happens there is dispersion, not dissolution. It is palpable because it is concentrated; spread it out and it stops being palpable, and the body resorbs it from there. The same paper states that sodium thiosulfate is not recommended — no advantage over saline was shown in controlled study, and it carries a risk of tissue necrosis and haemorrhage.
The vascular side is more cautious still
Far rarer but far more serious is intravascular injection. For hyaluronic acid filler there is an established emergency response: immediate hyaluronidase. Radiesse has no equivalent.
- There is no immediate reversal agent — so management centres on the general measures for restoring perfusion
- Which is precisely why the injection plan must be conservative — high-risk sites, plane, delivery method and bolus volume all come under stricter rules
- Cannula versus needle belongs to this conversation — see needle or cannula, and what differs
- The warning signs of vascular occlusion are set out in vascular occlusion: signs to know. Severe pain after treatment, blanching, or a spreading mottled pattern means contacting the clinic immediately, not waiting
This is why we talk at length about dilution and plane when explaining Radiesse. With a product that cannot be reversed, prevention matters overwhelmingly more than management.
What we actually do on the prevention side
- Settle the goal first — overall skin firmness versus filling a specific hollow lead to completely different dilutions and planes. They are different uses of the same product
- Design the dilution — diluting to lay it superficially and placing it near-undiluted and deep are different procedures. Set out in dilution ratio and injection plane
- Limit how much can pool in one place — small volumes divided across many points
- Keep a list of sites we do not use — we do not use Radiesse in the lips, following the warning in the instructions for use
- Verify the product together — the box, label and lot number are opened in front of the patient before treatment
Worth asking in consultation
- “Is my case about firmness or about volume?” — the answer decides dilution and plane
- “What dilution, and into which plane?”
- “What do you do if a nodule forms?” — if the answer is “we just dissolve it,” it is worth asking again
- “Can it be used in the lips?” — this is the site carrying a nodule warning in the approval data
- “If something seems wrong afterwards, when and how do I reach you?”
What we could not verify
- No study comparing success rates between the levels. The stepwise approach is an expert algorithm, not the result of randomised comparison
- Evidence that hyaluronidase helps with CaHA nodules is reported as anecdotal — and even then as aiding dispersion through surrounding tissue, not as breaking down CaHA
- We could not find a nodule rate for hyperdiluted, superficial skin-booster use. It is not the use the approval trials examined
- Time to resolution varies greatly with site and volume. Cases taking more than two years are reported
Radiesse nodules · frequently asked
Can Radiesse be dissolved?
No. Hyaluronidase is the enzyme for hyaluronic acid, and the substance in Radiesse is calcium hydroxylapatite, which gives the enzyme nothing to bind. “It can be dissolved if something goes wrong” applies to hyaluronic acid fillers, not to Radiesse.
But I heard hyaluronidase is used for Radiesse nodules.
It is not dissolving the Radiesse. It is an adjunct that dissolves the surrounding native hyaluronic acid so the deposit disperses more easily, and the evidence for it is reported as anecdotal.
How common are Radiesse nodules?
Uncommon in the approval data: one in 117 patients (0.9%) in the nasolabial fold study and none in 100 patients in the HIV-associated lipoatrophy study. Those studies examined deep volumising use, so the figure cannot be carried straight across to hyperdiluted superficial technique.
How is a nodule treated?
The reported stepwise approach is: observe and wait; hyperdilute the deposit in place with sterile water or saline and break it up with compression, massage, vibration or microneedling; then intralesional injection or fractional laser; and physical removal last. The principle is dispersion, not dissolution. Which step applies is decided by the treating physician.
Will a nodule go away on its own?
Most are reported to resolve with time, but cases taking more than two years are described. Whether to wait or intervene depends on site, size and visibility. If it is painful, red or visible, do not wait — go back to the clinic that treated you.
Can Radiesse be used in the lips?
The instructions for use carry an explicit warning that safety and effectiveness in the lips have not been established and that nodules associated with lip injection have been published. We do not use Radiesse in the lips.
What happens if Radiesse enters a vessel?
For hyaluronic acid filler there is an established emergency response with immediate hyaluronidase; Radiesse has no equivalent. Management therefore centres on general measures to restore perfusion, which is exactly why the injection plan has to be more conservative. Severe pain, blanching or a spreading mottled pattern after treatment means contacting the clinic immediately.
Where can I consult about Radiesse in Daegu?
Miso Clinic is at 4F Bombom Building, 125 Dongdeok-ro, Jung-gu, Daegu, South Korea, by Exit 1 of Kyungpook National University Hospital Station; +82-53-428-2700. Weekdays 11:00–19:00, Saturday 10:00–16:00, closed Sundays and public holidays. Cost depends on area and volume, so it is given by phone or at the consultation.
Read next
Product reference
Product reference for this treatment: Radiesse — CaHA collagen stimulator. Other boosters at Miso Clinic: Rejuran · Juvelook · Re2o · BYRYZN · collagen boosters compared
Who wrote this
This column was written and reviewed by Dr. Lee Chi-Hak, Medical Director of Miso Clinic in Daegu, South Korea. The treatment criteria and injection design are written exactly as we actually use them.
| Medical Director | Lee Chi-Hak |
|---|---|
| Address | 4F Bombom Building, 125 Dongdeok-ro, Jung-gu, Daegu, South Korea (Exit 1, Kyungpook National University Hospital Station) · Tower parking in the building |
| Phone | +82-53-428-2700 |
| KakaoTalk consultation | Miso Clinic Daegu channel |
| Opening hours | Weekdays 11:00–19:00 (lunch 13:00–14:00) / Saturday 10:00–16:00 (no lunch break) / Closed Sundays and public holidays |
| Clinical columns | See all columns |
| Reference library | All booster and lifting device references |
References
- Manufacturer instructions for use (Radiesse, US FDA P050037) — carries a warning that safety and effectiveness in the lips have not been established and that nodules associated with Radiesse injected into the lips have been published. Nodules were reported in 1 of 117 patients (0.9%) in the nasolabial fold study and 0 of 100 in the HIV-associated facial lipoatrophy study. Long-term safety and effectiveness beyond one year were not investigated in the clinical trials.
- A structured approach for treating calcium hydroxylapatite focal accumulations (Aesthetic Surgery Journal, 2024) — sets out a four-level algorithm: Level 0 observation (reported to resolve in most cases within about two and a half years); Level 1 in-situ hyperdilution with sterile water or saline plus compression, massage, vibration or microneedling; Level 2 intralesional injection (dexamethasone, triamcinolone, 5-fluorouracil) and fractional laser; Level 3 physical extraction or surgical removal. The same paper does not recommend sodium thiosulfate, stating controlled study showed no advantage over saline and that it carries a risk of tissue necrosis and haemorrhage. Hyaluronidase is mentioned as an anecdotally reported adjunct that may aid dispersion by dissolving endogenous hyaluronic acid, not as a means of breaking down CaHA.
- Expert consensus on intravascular complications with CaHA — unlike hyaluronic acid fillers, no immediate reversal enzyme exists, so preventive injection planning together with early recognition and perfusion-directed management are emphasised.
- The difference in reversibility — hyaluronidase acts specifically on hyaluronic acid. No corresponding degrading enzyme exists for CaHA, PDLLA or PLLA.
- What we could not verify — comparative success rates between the levels, nodule rates under hyperdiluted skin-booster technique, and the distribution of time to resolution.
- Korean medical advertising law — Medical Service Act Article 56(2), which prohibits testimonial advertising, comparison with other medical institutions and superlative claims.
- Fees and patient inducement — Medical Service Act Article 45 (disclosure of non-covered fees), Article 27(3) (prohibition of patient inducement for profit) and Article 56(2). This is why no price or discount appears in this column.
- Miso Clinic protocol — dilution designed to the goal, injection plane and per-session volume by site, exclusion of lip use, product-opening verification, and the contact pathway for adverse symptoms. This is the source for sentences marked as clinical judgement.
Everything in this column is general information and does not replace medical diagnosis or treatment. Effects and side effects vary with individual skin condition, age and underlying illness, and the same result is not guaranteed for everyone. Any decision to proceed should be made in an in-person consultation with a physician.
← Clinical columns · Reference library · Miso Clinic home
한국어 · English